Virology, epidemiology, pathogenesis, and control of enterovirus 71

The Lancet Infectious Diseases

Volumn 10, Issue 11, 2010, Pages 778-790

  Solomon, Tom ^a,b   Lewthwaite, Penny ^a   Perera, David ^c   Cardosa, Mary Jane ^c   McMinn, Peter ^e   Ooi, Mong How ^a,d  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b THE WALTON CENTRE NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITI MALAYSIA SARAWAK   (Malaysia)

^d Sibu Hospital   (Malaysia)

^e ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA VACCINE; ENTEROVIRUS 71 VACCINE; LIVE VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ASIA; BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR INFECTION; ENTEROVIRUS 71; HEART DISEASE; HEART FAILURE; HOST SUSCEPTIBILITY; HUMAN; LIFE CYCLE; LUNG EDEMA; LUNG INFECTION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; VIROLOGY; VIRUS ENTRY; VIRUS GENE; VIRUS INFECTION; VIRUS RECOMBINATION; VIRUS REPLICATION; VIRUS VIRULENCE;

ASIA; CALIFORNIA; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; HAND, FOOT AND MOUTH DISEASE; HUMANS; PACIFIC ISLANDS; VIRAL VACCINES;

EID: 78049398279     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(10)70194-8     Document Type: Review

References (127)

1. Pallansch MA, Ross RP Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. Fields Virology 2001, vol 1:723-775. Lippincott, Williams & Wilkins, Hagerstown, MD, USA, 1:. D.M. Knipe, P.M. Howley, D.E. Griffin (Eds.).
2. Schmidt N, Lennette E, Ho H An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 1974, 129:304-309.
3. Van der Sanden S, Koopmans M, Uslu G, Van der Avoort H Epidemiology of enterovirus 71 in The Netherlands, 1963 to 2008. J Clin Microbiol 2009, 47:2826-2833. on behalf of the Dutch Working Group for Clinical Virology.
4. Cardosa MJ, Krishnan S, Tio PH, Perera D, Wong SC Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-associated hand, foot, and mouth disease in Sibu, Sarawak. Lancet 1999, 354:987-991.
5. Chan K, Goh K, Chong C, Teo E, Lau G, Ling A Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis 2003, 9:78-85.
6. Chan L, Parashar U, Lye M, et al. Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease. Clin Infect Dis 2000, 31:678-683.
7. Ho M, Chen ER, Hsu KH, et al. An epidemic of enterovirus 71 infection in Taiwan. N Engl J Med 1999, 341:929-935.
8. McMinn P, Stratov I, Nagarajan L, Davis S Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis 2001, 32:236-242.
9. Tu PV, Thao NT, Perera D, et al. Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg Infect Dis 2007, 13:1733-1741.
10. Zhang Y, Tan X, Wang H, et al. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong. China J Clin Virol 2009, 44:262-267.
11. Komatsu H, Shimizu Y, Takeuchi Y, Ishiko H, Takada H Outbreak of severe neurologic involvement associated with Enterovirus 71 infection. Pediatr Neurol 1999, 20:17-23.
12. Zhang Y, Zhu Z, Yang W, et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of Hand Foot and Mouth Disease in Fuyang city of China. Virol J 2010, 7:94.
13. Cardosa MJ, Perera D, Brown B, et al. Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerg Infect Dis 2003, 9:461-468.
14. Shimizu H, Utama A, Onnimala N, et al. Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region. Pediatr Int 2004, 46:231-235.
15. Chen K, Chang H, Wang S, Cheng Y, Yang J Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998-2005. Pediatrics 2007, 120:244-252.
16. Jee YM, Cheon DS, Kim K, et al. Genetic analysis of the VP1 region of human enterovirus 71 strains isolated in Korea during 2000. Arch Virol 2003, 148:1735-1746.
17. Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF Neurologic complications in children with enterovirus 71 infection. N Engl J Med 1999, 341:936-942.
18. Chang LY, Huang YC, Lin TY Fulminant neurogenic pulmonary oedema with hand, foot, and mouth disease. Lancet 1998, 352:367-368.
19. Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T Clinical features, diagnosis and management of human enterovirus 71 infection. Lancet Neurol 2010, 9:1097-1105.
20. Nasri D, Bouslama L, Pillet S, Bourlet T, Aouni M, Pozzetto B Basic rationale, current methods and future directions for molecular typing of human enterovirus. Expert Rev Mol Diagn 2007, 7:419-434.
21. Brown B, Oberste M, Maher K, Pallansch M Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the noncapsid coding region. J Virol 2003, 77:8973-8984.
22. Brown BA, Pallansch MA Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res 1995, 39:195-205.
23. Chen CH, Hsu BM, Wan MT Molecular detection and prevalence of enterovirus within environmental water in Taiwan. J Appl Microbiol 2008, 104:817-823.
24. Hsu BM, Chen CH, Wan MT Prevalence of enteroviruses in hot spring recreation areas of Taiwan. FEMS Immunol Med Microbiol 2008, 52:253-259.
25. Chan YF, Bakar S Abu Virucidal activity of Virkon S on human enterovirus. Med J Malaysia 2005, 60:246-248.
26. De Jesus NH Epidemics to eradication: the modern history of poliomyelitis. Virol J 2007, 4:70.
27. Yamayoshi S, Yamashita Y, Li J, et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med 2009, 15:798-801.
28. Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med 2009, 15:794-797.
29. Yang B, Chuang H, Kuender DY Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol J 2009, 6:141.
30. Lin YW, Wang SW, Tung YY, Chen SH Enterovirus 71 infection of human dendritic cells. Exp Biol Med (Maywood) 2009, 234:1166-1173.
31. Zhou T, Chen YC, Hao L, Zhang Y DC-SIGN and immunoregulation. Cell Mol Immunol 2006, 3:279-283.
32. Tee KK, Lam TT, Chan YF, et al. Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J Virol 2010, 84:3339-3350.
33. Nobusawa E, Sato K Comparison of the mutation rates of human influenza A and B viruses. J Virol 2006, 80:3675-3678.
34. Kew OM, Sutter RW, Nottay BK, et al. Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol 1998, 36:2893-2899.
35. Deibel R, Flanagan TD Central nervous system infections. Etiologic and epidemiologic observations in New York State, 1976-1977. N Y State J Med 1979, 79:689-695.
36. Kennett ML, Birch CJ, Lewis FA Enterovirus type 71 infection in Melbourne. Bull World Health Organ 1975, 51:609-615.
37. Blomberg J, Lycke E, Ahlfors K, Johnsson T, Wolontis S, von Zeipel G New enterovirus type associated with epidemic of aseptic meningitis and-or hand, foot, and mouth disease. Lancet 1974, 2:112.
38. Ishimaru Y, Nakano S, Yamaoka K, Takami S Outbreaks of hand, foot, and mouth disease by enterovirus 71. High incidence of complication disorders of central nervous system. Arch Dis Child 1980, 55:583-588.
39. Hagiwara A, Tagaya I, Yoneyama T Epidemic of hand, foot and mouth disease associated with enterovirus 71 infection. Intervirology 1978, 9:60-63.
40. Chumakov M, Voroshilova M, Shindarov L Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol 1979, 60:329-340.
41. Shindarov LM, Chumakov MP, Voroshilova MK Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J Hyg Epidemiol Microbiol Immunol 1979, 23:284-295.
42. Nagy G, Takatsy S, Kukan E, Mihaly I, Domok I Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch Virol 1982, 71:217-227.
43. Samuda GM, Chang WK, Yeung CY, Tang PS Monoplegia caused by enterovirus 71: an outbreak in Hong Kong. Pediatr Infect Dis J 1987, 6:206-208.
44. Gilbert GL, Dickson KE, Waters MJ, Kennett ML, Land SA, Sneddon M Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement. Pediatr Infect Dis J 1988, 7:484-487.
45. McMinn P, Lindsay K, Perera D, Chan H, Chan K, Cardosa MJ Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol 2001, 75:7732-7738.
46. Huang YP, Lin TL, Kuo CY, et al. The circulation of subgenogroups B5 and C5 of enterovirus 71 in Taiwan from 2006 to 2007. Virus Res 2008, 137:206-212.
47. Lin KH, Hwang KP, Ke GM, et al. Evolution of EV71 genogroup in Taiwan from 1998 to 2005: an emerging of subgenogroup C4 of EV71. J Med Virol 2006, 78:254-262.
48. Huang SW, Hsu YW, Smith DJ, et al. Reemergence of enterovirus 71 in 2008 in Taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008. J Clin Microbiol 2009, 47:3653-3662.
49. Chua KB, Chua BH, Lee CS, et al. Genetic diversity of enterovirus 71 isolated from cases of hand, foot and mouth disease in the 1997, 2000 and 2005 outbreaks, Peninsular Malaysia. Malays J Pathol 2007, 29:69-78.
50. Jeong EJ, Lee JH, Kim MS, et al. Molecular characterization of enteroviruses detected in Gyeong-Ju and Po-Hang provinces of Korea in 2003. Arch Virol 2010, published online July 18. 10.1007/s00705-010-0755-4.
51. Chatproedprai S, Theanboonlers A, Korkong S, Thongmee C, Wananukul S, Poovorawan Y Clinical and molecular characterization of hand-foot-and-mouth disease in Thailand, 2008-2009. Jpn J Infect Dis 2010, 63:229-233.
52. Li L, He Y, Yang H, et al. Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J Clin Microbiol 2005, 43:3835-3889.
53. Brown BA, Oberste MS, Alexander JP, Kennett ML, Pallansch MA Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol 1999, 73:9969-9975.
54. Lum LC, Wong KT, Lam SK, et al. Fatal enterovirus 71 encephalomyelitis. J Pediatr 1998, 133:795-798.
55. Podin Y, Gias E, Ong F, et al. Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years. BMC Public Health 2006, 6:180.
56. Mizuta K, Abiko C, Murata T, et al. Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. J Clin Microbiol 2005, 43:6171-6175.
57. Hosoya M, Kawasaki Y, Sato M, et al. Genetic diversity of enterovirus 71 associated with hand, foot and mouth disease epidemics in Japan from 1983 to 2003. Pediatr Infect Dis J 2006, 25:691-694.
58. Prager P, Nolan M, Andrews I, Williams G Neurogenic pulmonary edema in enterovirus 71 encephalitis is not uniformly fatal but causes severe morbidity in survivors. Pediatr Crit Care Med 2003, 4:377-381.
59. Lum LC, Wong KT, Lam SK, Chua KB, Goh AY Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis. Lancet 1998, 352:1391.
60. Merovitz L, Demers AM, Newby D, McDonald J Enterovirus 71 infections at a Canadian center. Pediatr Infect Dis J 2000, 19:755-757.
61. Perez-Velez CM, Anderson MS, Robinson CC, et al. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis 2007, 45:950-957.
62. Ortner B, Huang CW, Schmid D, et al. Epidemiology of enterovirus types causing neurological disease in Austria 1999-2007: detection of clusters of echovirus 30 and enterovirus 71 and analysis of prevalent genotypes. J Med Virol 2009, 81:317-324.
63. Bible JM, Iturriza-Gomara M, Megson B, et al. Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006. J Clin Microbiol 2008, 46:3192-3200.
64. Witso E, Palacios G, Ronningen KS, et al. Asymptomatic circulation of HEV71 in Norway. Virus Res 2007, 123:19-29.
65. Welch J, Maclaran K, Jordan T, Simmonds P Frequency, viral loads, and serotype identification of enterovirus infections in Scottish blood donors. Transfusion 2003, 43:1060-1066.
66. Chakraborty R, Iturriza-Gomara M, Musoke R, Palakudy T, D'Agostino A, Gray J An epidemic of enterovirus 71 infection among HIV-1-infected orphans in Nairobi. AIDS 2004, 18:1968-1970.
67. Yu H, Chen W, Chang H, et al. Genetic analysis of the VP1 region of enterovirus 71 reveals the emergence of genotype A in central China in 2008. Virus Genes 2010, 41:1-4.
68. AbuBakar S, Sam IC, Yusof J, et al. Enterovirus 71 outbreak, Brunei. Emerg Infect Dis 2009, 15:79-82.
69. Sanders SA, Herrero LJ, McPhie K, et al. Molecular epidemiology of enterovirus 71 over two decades in an Australian urban community. Arch Virol 2006, 151:1003-1013.
70. McMinn P An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol 2002, 26:91-107.
71. Iwai M, Masaki A, Hasegawa S, et al. Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and mouth disease patients in Toyama, Japan between 1981 and 2007. Jpn J Infect Dis 2009, 62:254-259.
72. Deshpande JM, Nadkarni SS, Francis PP Enterovirus 71 isolated from a case of acute flaccid paralysis in India represents a new genotype. Curr Sci 2003, 84:1350-1353.
73. Lu CY, Lee CY, Kao CL, et al. Incidence and case-fatality rates resulting from the 1998 enterovirus 71 outbreak in Taiwan. J Med Virol 2002, 67:217-223.
74. Chang LY, King CC, Hsu KH, et al. Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan. Pediatrics 2002, 109:e88.
75. Wang JR, Tuan YC, Tsai HP, Yan JJ, Liu CC, Su IJ Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. J Clin Microbiol 2002, 40:10-15.
76. Van der Sanden S, Van der Avoort H, Lemey P, Uslu G, Koopmans M Evolutionary trajectory of the VP1 gene of human enterovirus 71 genogroup B and C viruses. J Gen Virol 2010, 91:1949-1958.
77. Mizuta K, Aoki Y, Suto A, et al. Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007. Vaccine 2009, 27:3153-3158.
78. Kung SH, Wang SF, Huang CW, Hsu CC, Liu HF, Yang JY Genetic and antigenic analyses of enterovirus 71 isolates in Taiwan during 1998-2005. Clin Microbiol Infect 2007, 13:782-787.
79. Simmonds P, Welch J Frequency and dynamics of recombination within different species of human enteroviruses. J Virol 2006, 80:483-493.
80. Chan Y, Abu Baker S Recombinant human enterovirus 71 in hand, foot and mouth disease patients. Emerg Infect Dis 2004, 10:1468-1470.
81. Shih S, Ho M, Lin K, et al. Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in Taiwan, 1998. Virus Res 2000, 68:127-136.
82. Singh S, Poh C, Chow V Complete sequence analyses of enterovirus 71 strains from fatal and non-fatal cases of the hand, foot and mouth disease outbreak in Singapore (2000). Microbiol Immunol 2002, 46:801-808.
83. Ooi MH, Wong SC, Podin Y, et al. Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study. Clin Infect Dis 2007, 44:646-656.
84. Ooi MH, Wong SC, Clear D, et al. Adenovirus type 21-associated acute flaccid paralysis during an outbreak of hand-foot-and-mouth disease in Sarawak, Malaysia. Clin Infect Dis 2003, 36:550-559.
85. Chang LY, Tsao KC, Hsia SH, et al. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA 2004, 291:222-227.
86. Chang LY, Chang IS, Chen WJ, et al. HLA-A33 is associated with susceptibility to enterovirus 71 infection. Pediatrics 2008, 122:1271-1276.
87. Yang KD, Yang MY, Li CC, et al. Altered cellular but not humoral reactions in children with complicated enterovirus 71 infections in Taiwan. J Infect Dis 2001, 183:850-856.
88. Chung P, Huang Y, Chang L, Lin T, Ning H Duration of enterovirus shedding in stool. J Microbiol Immunol Infect 2001, 34:167-170.
89. Chen CS, Yao YC, Lin SC, et al. Retrograde axonal transport: a major transmission route of enterovirus 71 in mice. J Virol 2007, 81:8996-9003.
90. Wong KT, Munisamy B, Ong KC, et al. The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J Neuropathol Exp Neurol 2008, 67:162-169.
91. Ong KC, Badmanathan M, Devi S, Leong KL, Cardosa MJ, Wong KT Pathologic characterization of a murine model of human enterovirus 71 encephalomyelitis. J Neuropathol Exp Neurol 2008, 67:532-542.
92. Shieh WJ, Jung SM, Hsueh C, et al. Pathologic studies of fatal cases in outbreak of hand, foot, and mouth disease, Taiwan. Emerg Infect Dis 2001, 7:146-148.
93. Hsueh C, Jung SM, Shih SR, et al. Acute encephalomyelitis during an outbreak of enterovirus type 71 infection in Taiwan: report of an autopsy case with pathologic, immunofluorescence, and molecular studies. Mod Pathol 2000, 13:1200-1205.
94. Shen WC, Chiu HH, Chow KC, Tsai CH MR imaging findings of enteroviral encephalomyelitis: an outbreak in Taiwan. Am J Neuroradiol 1999, 20:1889-1895.
95. German AC, Myint KS, Mai NT, et al. A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model. Trans R Soc Trop Med Hyg 2006, 100:1135-1145.
96. Hoff JT, Nishimura M, Garcia-Uria J, Miranda S Experimental neurogenic pulmonary edema. Part 1: The role of systemic hypertension. J Neurosurg 1981, 54:627-631.
97. Baker AB Poliomyelitis. A study of pulmonary edema. Neurology 1957, 7:743-751.
98. Chang LY, Lin TY, Hsu KH, et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 1999, 354:1682-1686.
99. Lin TY, Chang LY, Hsia SH, et al. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis 2002, 34(suppl 2):S52-S57.
100. Wu JM, Wang JN, Tsai YC, et al. Cardiopulmonary manifestations of fulminant enterovirus 71 infection. Pediatrics 2002, 109:e26.
101. Fu YC, Chi CS, Chiu YT, et al. Cardiac complications of enterovirus rhombencephalitis. Arch Dis Child 2004, 89:368-373.
102. Huang YF, Chiu PC, Chen CC, et al. Cardiac troponin I: a reliable marker and early myocardial involvement with meningoencephalitis after fatal enterovirus-71 infection. J Infect 2003, 46:238-243.
103. Fu YC, Chi CS, Jan SL, et al. Pulmonary edema of enterovirus 71 encephalomyelitis is associated with left ventricular failure: implications for treatment. Pediatr Pulmonol 2003, 35:263-268.
104. Fu YC, Chi CS, Lin NN, et al. Comparison of heart failure in children with enterovirus 71 rhombencephalitis and cats with norepinephrine cardiotoxicity. Pediatr Cardiol 2006, 27:577-584.
105. Lin TY, Hsia SH, Huang YC, Wu CT, Chang LY Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin Infect Dis 2003, 36:269-274.
106. Lin TY, Chang LY, Huang YC, Hsu KH, Chiu CH, Yang KD Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta Paediatr 2002, 91:632-635.
107. Wang SM, Lei HY, Huang KJ, et al. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis 2003, 188:564-570.
108. Wang SM, Lei HY, Yu CK, Wang JR, Su IJ, Liu CC Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis. J Infect Dis 2008, 198:1002-1006.
109. Ooi MH, Wong S, Mohan A, et al. Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak. BMC Infect Dis 2009, 9:3.
110. Chang LY, Hsia SH, Wu CT, et al. Outcome of enterovirus 71 infections with or without stage-based management: 1998 to 2002. Pediatr Infect Dis J 2004, 23:327-331.
111. Wang S, Lei H, Huang M, et al. Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. J Clin Virol 2006, 37:47-52.
112. Chen YC, Yu CK, Wang YF, Liu CC, Su IJ, Lei HY A murine oral enterovirus 71 infection model with central nervous system involvement. J Gen Virol 2004, 85:69-77.
113. Arita M, Shimizu H, Nagata N, et al. Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J Gen Virol 2005, 86:1391-1401.
114. Wang YF, Chou CT, Lei HY, et al. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol 2004, 78:7916-7924.
115. Ang LW, Koh BK, Chan KP, Chua LT, James L, Goh KT Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. Ann Acad Med Singapore 2009, 38:106-112.
116. Forum on Hand Foot and Mouth Disease (HFMD) in Asia-Pacific Region: Epidemiological, Laboratory, Clinical, and Public Health aspects 2009, Regional Emerging Disease Intervention Center and The Ministry of Health Singapore, Singapore.
117. Wu CN, Lin YC, Fann C, Liao NS, Shih SR, Ho MS Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 2001, 20:895-904.
118. Xu J, Qian Y, Wang S, et al. EV71: An emerging infectious disease vaccine target in the Far East?. Vaccine 2010, 28:3516-3521.
119. Lee MS, Chang LY Development of enterovirus 71 vaccines. Expert Rev Vaccines 2010, 9:149-156.
120. Liu CC, Lian WC, Butler M, Wu SC High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture. Vaccine 2007, 25:19-24.
121. Chung YC, Ho MS, Wu JC, et al. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 2008, 26:1855-1862.
122. Tung WS, Bakar SA, Sekawi Z, Rosli R DNA vaccine constructs against enterovirus 71 elicit immune response in mice. Genet Vaccines Ther 2007, 5:6.
123. Chiu CH, Chu C, He CC, Lin TY Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71. Microbes Infect 2006, 8:1671-1678.
124. Chen HF, Chang MH, Chiang BL, Jeng ST Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71. Vaccine 2006, 24:2944-2951.
125. Foo DG, Alonso S, Phoon MC, Ramachandran NP, Chow VT, Poh CL Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides. Virus Res 2007, 125:61-68.
126. Arita M, Nagata N, Iwata N, et al. An attenuated strain of enterovirus 71 belonging to genotype A showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. J Virol 2007, 81:9386-9395.
127. Solomon T Flavivirus encephalitis. N Engl J Med 2004, 351:370-378.